SFCM
CATX icon

Seven Fleet Capital Management’s Perspective Therapeutics CATX Stock Holding History

Seven Fleet Capital Management’s Portfolio CATX Stock Details CATX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.13M Sell
332,613
-46,469
-12% -$176K 0.19% 56
2026
Q1 		$1.58M Buy
+379,082
New +$1.6M 0.5% 46

Other funds holding CATX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM

Seven Fleet Capital Management's CATX Position: Q2 2026 in Review

Seven Fleet Capital Management reduced its Perspective Therapeutics (CATX) stake by 12% in Q2 2026, selling an estimated $176K and leaving 332,613 shares worth $1.13M. The position accounts for 0.19% of the portfolio, ranked #56.

Seven Fleet Capital Management first reported a position in CATX in Q1 2026 and has held it in 2 quarters since. The position peaked at $1.58M in Q1 2026. 131 funds tracked by Wall St. Rank hold CATX as of Q2 2026.

  • Seven Fleet Capital Management held 332,613 shares of Perspective Therapeutics worth $1.13M as of Q2 2026.
  • Seven Fleet Capital Management sold 46,469 Perspective Therapeutics shares in Q2 2026, an estimated $176K.
  • Perspective Therapeutics made up 0.19% of Seven Fleet Capital Management's portfolio in Q2 2026, its #56 holding.
  • Seven Fleet Capital Management first reported a position in Perspective Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • Seven Fleet Capital Management's Perspective Therapeutics position peaked at $1.58M in Q1 2026.
  • 131 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q2 2026.

Based on Seven Fleet Capital Management's 13F filing for Q2 2026, filed 17 Aug 2026.